Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-20

Clinical Trial Update: Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating focused ultrasound targeting the default mode network to reduce depressive symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arizona | Conditions: Depressive Disorder, Major, Depression | Phase 1, Phase 2 | Status: UNKNOWN